Merck (MRK) Receivables - Net (2009 - 2026)

Merck (MRK) has 18 years of Receivables - Net data on file, last reported at $12.2 billion in Q1 2026.

• Receivables - Net for Q1 2026 came in at $12.2 billion, up 13.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 billion (up 13.16% YoY), and the FY2025 annual result was $11.8 billion, up 14.57% from the prior year.
• Receivables - Net improved to $12.2 billion in Q1 2026 per MRK's latest filing, from $11.8 billion in the prior quarter.
• Over five years, Receivables - Net peaked at $12.2 billion in Q1 2026 and troughed at $129.0 million in Q1 2022.
• A 5-year average of $8.6 billion and a median of $10.8 billion in 2025 frame the typical range for Receivables - Net.
• On a YoY basis, Receivables - Net climbed as much as 7973.64% in 2023 and fell as far as 10.34% in 2023.
• A 5-year view of Receivables - Net shows it stood at $9.5 billion in 2022, then gained by 9.51% to $10.3 billion in 2023, then declined by 0.69% to $10.3 billion in 2024, then gained by 14.57% to $11.8 billion in 2025, then climbed by 3.69% to $12.2 billion in 2026.
• Business Quant data shows MRK's Receivables - Net at $12.2 billion in Q1 2026, $11.8 billion in Q4 2025, and $12.1 billion in Q3 2025.